- •Dedication
- •Editors and Contributors
- •Foreword
- •Preface
- •Contents
- •PREPARING FOR THE SURGERY CLERKSHIP
- •SURGICAL NOTES
- •COMMON ABBREVIATIONS YOU SHOULD KNOW
- •RETRACTORS (YOU WILL GET TO KNOW THEM WELL!)
- •SUTURE MATERIALS
- •WOUND CLOSURE
- •KNOTS AND EARS
- •INSTRUMENT TIE
- •TWO-HAND TIE
- •COMMON PROCEDURES
- •NASOGASTRIC TUBE (NGT) PROCEDURES
- •CHEST TUBES
- •NASOGASTRIC TUBES (NGT)
- •FOLEY CATHETER
- •CENTRAL LINES
- •MISCELLANEOUS
- •THIRD SPACING
- •COMMON IV REPLACEMENT FLUIDS (ALL VALUES ARE PER LITER)
- •CALCULATION OF MAINTENANCE FLUIDS
- •ELECTROLYTE IMBALANCES
- •ANTIBIOTICS
- •STEROIDS
- •HEPARIN
- •WARFARIN (COUMADIN®)
- •MISCELLANEOUS AGENTS
- •NARCOTICS
- •MISCELLANEOUS
- •ATELECTASIS
- •POSTOPERATIVE RESPIRATORY FAILURE
- •PULMONARY EMBOLISM
- •ASPIRATION PNEUMONIA
- •GASTROINTESTINAL COMPLICATIONS
- •ENDOCRINE COMPLICATIONS
- •CARDIOVASCULAR COMPLICATIONS
- •MISCELLANEOUS
- •HYPOVOLEMIC SHOCK
- •SEPTIC SHOCK
- •CARDIOGENIC SHOCK
- •NEUROGENIC SHOCK
- •MISCELLANEOUS
- •URINARY TRACT INFECTION (UTI)
- •CENTRAL LINE INFECTIONS
- •WOUND INFECTION (SURGICAL SITE INFECTION)
- •NECROTIZING FASCIITIS
- •CLOSTRIDIAL MYOSITIS
- •SUPPURATIVE HIDRADENITIS
- •PSEUDOMEMBRANOUS COLITIS
- •PROPHYLACTIC ANTIBIOTICS
- •PAROTITIS
- •MISCELLANEOUS
- •CHEST
- •ABDOMEN
- •MALIGNANT HYPERTHERMIA
- •MISCELLANEOUS
- •OVERVIEW
- •CHOLECYSTOKININ (CCK)
- •SECRETIN
- •GASTRIN
- •SOMATOSTATIN
- •MISCELLANEOUS
- •GROIN HERNIAS
- •HERNIA REVIEW QUESTIONS
- •ESOPHAGEAL HIATAL HERNIAS
- •PRIMARY SURVEY
- •SECONDARY SURVEY
- •TRAUMA STUDIES
- •PENETRATING NECK INJURIES
- •MISCELLANEOUS TRAUMA FACTS
- •PEPTIC ULCER DISEASE (PUD)
- •DUODENAL ULCERS
- •GASTRIC ULCERS
- •PERFORATED PEPTIC ULCER
- •TYPES OF SURGERIES
- •STRESS GASTRITIS
- •MALLORY-WEISS SYNDROME
- •ESOPHAGEAL VARICEAL BLEEDING
- •BOERHAAVE’S SYNDROME
- •ANATOMY
- •GASTRIC PHYSIOLOGY
- •GASTROESOPHAGEAL REFLUX DISEASE (GERD)
- •GASTRIC CANCER
- •GIST
- •MALTOMA
- •GASTRIC VOLVULUS
- •SMALL BOWEL
- •APPENDICITIS
- •CLASSIC INTRAOPERATIVE QUESTIONS
- •APPENDICEAL TUMORS
- •SPECIFIC TYPES OF FISTULAS
- •ANATOMY
- •COLORECTAL CARCINOMA
- •COLONIC AND RECTAL POLYPS
- •POLYPOSIS SYNDROMES
- •DIVERTICULAR DISEASE OF THE COLON
- •ANATOMY
- •ANAL CANCER
- •ANATOMY
- •TUMORS OF THE LIVER
- •ABSCESSES OF THE LIVER
- •HEMOBILIA
- •ANATOMY
- •PHYSIOLOGY
- •PATHOPHYSIOLOGY
- •DIAGNOSTIC STUDIES
- •BILIARY SURGERY
- •OBSTRUCTIVE JAUNDICE
- •CHOLELITHIASIS
- •ACUTE CHOLECYSTITIS
- •ACUTE ACALCULOUS CHOLECYSTITIS
- •CHOLANGITIS
- •SCLEROSING CHOLANGITIS
- •GALLSTONE ILEUS
- •CARCINOMA OF THE GALLBLADDER
- •CHOLANGIOCARCINOMA
- •MISCELLANEOUS CONDITIONS
- •PANCREATITIS
- •PANCREATIC ABSCESS
- •PANCREATIC NECROSIS
- •PANCREATIC PSEUDOCYST
- •PANCREATIC CARCINOMA
- •MISCELLANEOUS
- •ANATOMY OF THE BREAST AND AXILLA
- •BREAST CANCER
- •DCIS
- •LCIS
- •MISCELLANEOUS
- •MALE BREAST CANCER
- •BENIGN BREAST DISEASE
- •CYSTOSARCOMA PHYLLODES
- •FIBROADENOMA
- •FIBROCYSTIC DISEASE
- •MASTITIS
- •BREAST ABSCESS
- •MALE GYNECOMASTIA
- •ADRENAL GLAND
- •ADDISON’S DISEASE
- •INSULINOMA
- •GLUCAGONOMA
- •SOMATOSTATINOMA
- •ZOLLINGER-ELLISON SYNDROME (ZES)
- •MULTIPLE ENDOCRINE NEOPLASIA
- •THYROID DISEASE
- •ANATOMY
- •PHYSIOLOGY
- •HYPERPARATHYROIDISM (HPTH)
- •PARATHYROID CARCINOMA
- •SOFT TISSUE SARCOMAS
- •LYMPHOMA
- •SQUAMOUS CELL CARCINOMA
- •BASAL CELL CARCINOMA
- •MISCELLANEOUS SKIN LESIONS
- •STAGING
- •INTENSIVE CARE UNIT (ICU) BASICS
- •INTENSIVE CARE UNIT FORMULAS AND TERMS YOU SHOULD KNOW
- •SICU DRUGS
- •INTENSIVE CARE PHYSIOLOGY
- •HEMODYNAMIC MONITORING
- •MECHANICAL VENTILATION
- •PERIPHERAL VASCULAR DISEASE
- •LOWER EXTREMITY AMPUTATIONS
- •ACUTE ARTERIAL OCCLUSION
- •ABDOMINAL AORTIC ANEURYSMS
- •MESENTERIC ISCHEMIA
- •MEDIAN ARCUATE LIGAMENT SYNDROME
- •CAROTID VASCULAR DISEASE
- •CLASSIC CEA INTRAOP QUESTIONS
- •SUBCLAVIAN STEAL SYNDROME
- •RENAL ARTERY STENOSIS
- •SPLENIC ARTERY ANEURYSM
- •POPLITEAL ARTERY ANEURYSM
- •MISCELLANEOUS
- •PEDIATRIC IV FLUIDS AND NUTRITION
- •PEDIATRIC BLOOD VOLUMES
- •FETAL CIRCULATION
- •ECMO
- •NECK
- •ASPIRATED FOREIGN BODY (FB)
- •CHEST
- •PULMONARY SEQUESTRATION
- •ABDOMEN
- •INGUINAL HERNIA
- •UMBILICAL HERNIA
- •GERD
- •CONGENITAL PYLORIC STENOSIS
- •DUODENAL ATRESIA
- •MECONIUM ILEUS
- •MECONIUM PERITONITIS
- •MECONIUM PLUG SYNDROME
- •ANORECTAL MALFORMATIONS
- •HIRSCHSPRUNG’S DISEASE
- •MALROTATION AND MIDGUT VOLVULUS
- •OMPHALOCELE
- •GASTROSCHISIS
- •POWER REVIEW OF OMPHALOCELE AND GASTROSCHISIS
- •APPENDICITIS
- •INTUSSUSCEPTION
- •MECKEL’S DIVERTICULUM
- •NECROTIZING ENTEROCOLITIS
- •BILIARY TRACT
- •TUMORS
- •PEDIATRIC TRAUMA
- •OTHER PEDIATRIC SURGERY QUESTIONS
- •POWER REVIEW
- •WOUND HEALING
- •SKIN GRAFTS
- •FLAPS
- •SENSORY SUPPLY TO THE HAND
- •CARPAL TUNNEL SYNDROME
- •ANATOMY
- •MISCELLANEOUS
- •NOSE AND PARANASAL SINUSES
- •ORAL CAVITY AND PHARYNX
- •FACIAL FRACTURES
- •ENT WARD QUESTIONS
- •RAPID-FIRE REVIEW OF MOST COMMON CAUSES OF ENT INFECTIONS
- •THORACIC OUTLET SYNDROME (TOS)
- •CHEST WALL TUMORS
- •DISEASES OF THE PLEURA
- •DISEASES OF THE LUNGS
- •DISEASES OF THE MEDIASTINUM
- •DISEASES OF THE ESOPHAGUS
- •ACQUIRED HEART DISEASE
- •CONGENITAL HEART DISEASE
- •CARDIAC TUMORS
- •DISEASES OF THE GREAT VESSELS
- •MISCELLANEOUS
- •BASIC IMMUNOLOGY
- •CELLS
- •IMMUNOSUPPRESSION
- •OVERVIEW OF IMMUNOSUPPRESSION MECHANISMS
- •MATCHING OF DONOR AND RECIPIENT
- •REJECTION
- •ORGAN PRESERVATION
- •KIDNEY TRANSPLANT
- •LIVER TRANSPLANT
- •PANCREAS TRANSPLANT
- •HEART TRANSPLANT
- •INTESTINAL TRANSPLANTATION
- •LUNG TRANSPLANT
- •TRANSPLANT COMPLICATIONS
- •ORTHOPAEDIC TERMS
- •TRAUMA GENERAL PRINCIPLES
- •FRACTURES
- •ORTHOPAEDIC TRAUMA
- •DISLOCATIONS
- •THE KNEE
- •ACHILLES TENDON RUPTURE
- •ROTATOR CUFF
- •MISCELLANEOUS
- •ORTHOPAEDIC INFECTIONS
- •ORTHOPAEDIC TUMORS
- •ARTHRITIS
- •PEDIATRIC ORTHOPAEDICS
- •HEAD TRAUMA
- •SPINAL CORD TRAUMA
- •TUMORS
- •VASCULAR NEUROSURGERY
- •SPINE
- •PEDIATRIC NEUROSURGERY
- •SCROTAL ANATOMY
- •UROLOGIC DIFFERENTIAL DIAGNOSIS
- •RENAL CELL CARCINOMA (RCC)
- •BLADDER CANCER
- •PROSTATE CANCER
- •BENIGN PROSTATIC HYPERPLASIA
- •TESTICULAR CANCER
- •TESTICULAR TORSION
- •EPIDIDYMITIS
- •PRIAPISM
- •ERECTILE DYSFUNCTION
- •CALCULUS DISEASE
- •INCONTINENCE
- •URINARY TRACT INFECTION (UTI)
- •MISCELLANEOUS UROLOGY QUESTIONS
- •Rapid Fire Power Review
- •TOP 100 CLINICAL SURGICAL MICROVIGNETTES
- •Figure Credits
- •Index
134 Section I / Overview and Background Surgical Information
What laboratory test should be used to follow effect?
What is the standard lab target for therapeutic heparinization?
Who is at risk for a protamine anaphylactic reaction?
What is the half-life of heparin?
How long before surgery should it be discontinued?
Does heparin dissolve clots?
aPTT—activated partial thromboplastin time
1.5–2.5 times control or measured antifactor X level
Patients with type 1 diabetes mellitus, s/p prostate surgery
90 minutes (1–2 hours)
From 4 to 6 hours preoperatively
No; it stops the progression of clot formation and allows the body’s own fibrinolytic systems to dissolve the clot
What is LMWH? |
Low Molecular Weight Heparin |
What laboratory test do you |
None, except in children, patients with |
need to follow LMWH? |
obesity, and those with renal failure, |
|
which is the major advantage of LMWH |
|
(check factor X levels) |
WARFARIN (COUMADIN®) |
|
ACRONYM basis for name? |
Wisconsin Alumni Research Foundation |
Describe its action. |
Inhibits vitamin K–dependent clotting |
|
factors II, VII, IX, and X, (i.e., 2, 7, 9 |
|
and 10 [Think: 2 7 9 and 10]), |
|
produced in the liver |
What are its uses? |
Long-term anticoagulation (PO) |
What are its associated risks? |
Bleeding complications, teratogenic in |
|
pregnancy, skin necrosis, dermatitis |
What laboratory test should |
PT (prothrombin time) as reported as INR |
be used to follow its effect? |
|
What is INR? |
International Normalized Ratio |
|
Chapter 21 / Common Surgical Medications 135 |
What is the classic therapeutic |
INR of 2–3 |
INR? |
|
What is the half-life of |
40 hours; thus, it takes about 2 days to |
effect? |
observe a change in the PT |
What reverses the action? |
Cessation, vitamin K, fresh-frozen |
|
plasma (in emergencies) |
How long before surgery |
From 3 to 5 days preoperatively and IV |
should it be discontinued? |
heparin should be begun; heparin should |
|
be discontinued from 4 to 6 hours |
|
preoperatively and can be restarted |
|
postoperatively; Coumadin® can be |
|
restarted in a few days |
How can warfarin cause skin necrosis when first started?
Initially depressed protein C and S result in a HYPERcoagulable state! Avoid by using heparin concomitantly when starting
MISCELLANEOUS AGENTS
Describe the following |
|
drugs: |
|
Sucralfate (Carafate®) |
Treats peptic ulcers by forming an acid- |
|
resistant barrier; binds to ulcer craters; |
|
needs acid to activate and thus should |
|
not be used with H2 blockers |
Cimetidine (Tagamet®) |
H2 blocker (ulcers/gastritis) |
Ranitidine (Zantac®) |
H2 blocker (ulcers/gastritis) |
Ondansetron (Zofran®) |
Antinausea |
|
Anti-emetic |
PPI |
Proton-Pump Inhibitor: Gastric acid– |
|
secretion inhibitor; works by inhibiting |
|
the K /H -ATPase (e.g., omeprazole |
|
[Prilosec®]) |
Promethazine |
Acute antinausea agent; used |
(Phenergan®) |
postoperatively |
136 Section I / Overview and Background Surgical Information
Metoclopramide (Reglan®) |
Increases gastric emptying with increase |
|
in LES pressure; dopamine antagonist; |
|
used in diabetic gastroparesis and to help |
|
move feeding tubes past the pylorus |
Haloperidol (Haldol®) |
Sedative/antipsychotic (side effects |
|
extrapyramidal symptoms, QT |
|
prolongation) |
Ondansetron (Zofran®)
Albumin
Anti-emetic/serotonin receptor blocker
5% albumin
25% albumin—draws extravascular fluid into intravascular space by oncotic pressure
Albuterol
Octreotide
Famotidine (Pepcid®)
Aspirin
Furosemide (Lasix®)
Dantrolene (Dantrium®)
Misoprostol (Cytotec®)
What is an antibiotic option for colon/appendectomy coverage if the patient is allergic to penicillin?
If the patient does not respond to a dose of furosemide, should the dose be repeated, increased, or decreased?
Inhaled 2 agonist (bronchodilator)
Somatostatin analog
H2 blocker
Irreversibly inhibits platelets by irreversibly inhibiting cyclooxygenase
Loop diuretic (watch for hypokalemia)
Medication used to treat malignant hyperthermia
Prostaglandin E1 analog Gastroduodenal mucosal protection
1.IV ciprofloxacin (Cipro) AND
2.IV clindamycin or IV Flagyl
Dose should be doubled if there is no response to the initial dose
|
Chapter 21 / Common Surgical Medications 137 |
What medication is used to |
Diphenhydramine hydrochloride IV |
treat promethazine-induced |
(Benadryl®) |
dystonia? |
|
Which medication is |
Digitalis |
classically associated with |
|
mesenteric ischemia? |
|
What type of antihypertensive |
ACE inhibitors |
medication is contraindicated |
|
in patients with renal artery |
|
stenosis? |
|
Does acetaminophen |
No |
(Tylenol®) inhibit platelets? |
|
What medications are used |
Benzodiazepines (e.g., lorazepam |
to stop seizures? |
[Ativan®]); phenytoin (Dilantin®) |
List examples of preop |
|
antibiotics for: |
Ancef ® (gram-positive coverage) |
Vascular prosthetic |
|
graft |
|
Appendectomy |
Cefoxitin, Unasyn® (anaerobic coverage) |
Colon surgery |
Cefoxitin, Unasyn® (anaerobic coverage) |
NARCOTICS |
|
|
|
What are common postoperative IV narcotics?
What is Percocet®
What is Demerol’s claim to fame?
Morphine (most common), meperidine (Demerol®), fentanyl, Percocet®, Dilaudid®
PO narcotic pain reliever with acetaminophen and oxycodone
Used commonly with acute pancreatitis/ biliary pathology because classically morphine may cause sphincter of Oddi spasm/constriction
What are side effects of |
Respiratory depression, hypotension, |
narcotics? |
itching, bradycardia, nausea |